Globus Medical Inc (GMED) stock is up 49.16% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives GMED stock a score of 69 out of a possible 100. That rank is primarily influenced by a short-term technical score of 93. GMED's rank also includes a long-term technical score of 83. The fundamental score for GMED is 31. In addition to the average rating from Wall Street analysts, GMED stock has a mean target price of $85.73. This means analysts expect the stock to climb 4.42% over the next 12 months.
GMED has an Overall Score of 69. Find out what this means to you and get the rest of the rankings on GMED!